Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle c myc'

Search results for: 'research area cell cycle c myc'

Items 11-20 of 25

Page
per page
  1. Bortezomib (PS-341)
    A2614 Bortezomib (PS-341)
     24 Citation
    Target: Proteasome
    Summary: Proteasome Inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL
  2. MG-132
    A2585 MG-132
     26 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, Cell permeable, reversible
      ≥23.78 mg/mL
  3. MG-262
    A8179 MG-262
     1 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      ≥24.57 mg/mL
  4. (-)-Blebbistatin
    B1387 (-)-Blebbistatin
     3 Citation
    Target: Myosin II ATPases
    Summary: Non muscle myosin II ATPase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.62 mg/mL
  5. SC-514
    B1585 SC-514
    Summary: ATP-competitive IKK-2 inhibitor, orally active
      insoluble in EtOH; insoluble in H2O; ≥50.4 mg/mL
  6. GlyH-101
    B1087 GlyH-101
    Target: CFTR
    Summary: CFTR Inhibitor II
      insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL
  7. Trichostatin A (TSA)
    A8183 Trichostatin A (TSA)
     13 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; ≥15.12 mg/mL
  8. Nocodazole
    A8487 Nocodazole
     1 Citation
    Target: Microtubules/Tubulins
    Summary: Tubulin production inhibitor,anti-neoplastic agent
      insoluble in H2O; insoluble in EtOH; ≥15.066 mg/mL
  9. Dabrafenib (GSK2118436)
    B1407 Dabrafenib (GSK2118436)
     3 Citation
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥26 mg/mL
  10. Dynasore
    A1605 Dynasore
     4 Citation
    Target: GTPases
    Summary: Dynamin and GTPase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥16.12 mg/mL

Items 11-20 of 25

Page
per page